Home » Newsletters » BioWorld

BioWorld

Aug. 4, 1994

View Archived Issues

GERON CORP. RAISES $12.6M IN THIRD ROUND OF FINANCING

APPOINTMENTS AND ADVANCEMENTS

MEDAREX ENROLLING PATIENTS FOR MDX-240 AIDS TRIAL

CLARIFICATION

CYTEL STARTS PHASE II OF CYLEXIN

SERAGEN, LILLY FINALIZE DEAL ON IL-2 FUSION TOXIN

GILEAD SCIENCES BEGINS PHASE I/II TRIALS FOR HIV TREATMENT

ALLEGED KILLER ANTIBODY HAS UNSUSPECTED ACCOMPLICES, EXPERIMENT SHOWS

RHONE-POULENC FILES FOR FDA APPROVAL OF TAXOTERE

LIPOSOME EXPANDS DOX-SL PROGRAM WITH 3 NEW TRIALS

GLIATECH DATA BACKS STRATEGY FOR SLOWING ALZHEIMER'S PROGRESS